Hi ,

While much of the US slows down for Thanksgiving, I’ve been piecing together some big updates — worth a read if you’re in weekend mode.

Skincare is supposed to help. But sometimes, that innocent-looking cream quietly becomes a trigger.
→ Read: Vitiligo and Other Skin Problems Hidden in Everyday Products

📊 Opzelura: When Reddit Beats the Trials

TRuE-V studies confirmed what patients already shared online: Opzelura helps, yet the story is multidimensional.
→ Read: TRuE-V Studies Confirm What Reddit Already Told Us

🧠  Vitiligo and Mental Health: What Drugs Do to the Body

A closer look at antidepressants, stress, and skin — and how to choose safer options when it matters.
→ Read: How Antidepressants Shape the Body

💹 Vitiligo Drug Pipeline Update

Updated sales numbers, shifting market drivers, and pipeline reprioritization are reshaping the field. No big moves in M&A this quarter — just quiet recalibrations behind the scenes.
→ Read: Vitiligo Drug Pipeline & Market Insights

🧩 Rethinking Vitiligo: It’s Not One Disease

What if we’ve been lumping five conditions into one? A field guide to the real-life faces of vitiligo.
→ Read: Five Distinct Faces of a Complex Disease

✋ Hand Vitiligo: A New Classification Proposed

Osaka University’s team has cracked a clearer way to talk about vitiligo on hands. Here’s what it changes.
→ Read: Defining the Landscape of Hand Vitiligo

👶 Children’s Clinical Trial in Montana – Participants Needed

The TRuE-ViP Trial is testing a new cream for young kids with vitiligo.
If you’re near Missoula, Montana, this study might be an option — and it’s completely free to join.
→ Learn More & Share: Clinical Study for Young Children with Vitiligo

📫 That’s a wrap for November.

Got feedback? Got questions? Hit reply — I actually read it.

Enjoy the lovely weekend,